Author

M. W. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:protein structure· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Y. Ting· 1 shared B.-S. Han· 1 shared C. K. Kim· 1 shared D. Kim· 1 shared E. Jang· 1 shared E.-W. Lee· 1 shared G.-S. Hwang· 1 shared H. Y. Son· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Y. Ting

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The role of positively charged small biomolecules in the aggregation of hyperphosphorylated tau in Alzheimer's disease

J. Lee, K. Lee, M. S. Kim, M. W. Kim, M. Lim, J. Yoo, S. H. Lee

This study identifies electrostatic interactions between hyperphosphorylated tau and polyamines as crucial for tau aggregation in Alzheimer's disease and observes the transition from aggregates to fibrils.

bioRxiv · Oct 19, 2023 · PreprintBiophysics

Darapladib, an inhibitor of Lp-PLA2, sensitizes cancer cells to ferroptosis by remodeling lipid metabolism

M. Oh, S. Y. Jang, J.-Y. Lee, J. W. Kim, Y. Jung, J. Seo, T.-S. Han, E. Jang, H. Y. Son, D. Kim, M. W. Kim, K.-H. Song, K.-J. Oh, W. K. Kim, K.-H. Bae, , E.-W. Lee

This study shows that darapladib, an Lp-PLA2 inhibitor, enhances ferroptosis in cancer cells by altering lipid metabolism and synergizes with GPX4 inhibitors to suppress tumor growth.

bioRxiv · Apr 8, 2023 · PreprintCancer Biology

Luciferase-LOV BRET enables versatile and specific transcriptional readout of cellular protein-protein interactions

C. K. Kim, K. F. Cho, M. W. Kim, A. Y. Ting

The paper introduces SPARK2, a transcriptional readout system for PPIs using luciferase-LOV BRET, enabling high-throughput screening and specific detection of interactions.

bioRxiv · Mar 18, 2019Bioengineering